Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01631552 |
|---|---|
| Brief Title: | Study of Sacituzumab Govitecan (IMMU-132) in Adults With Epithelial Cancer |
| First Submitted : | June 26, 2012 |
| First Submitted that Met QC Criteria : | June 27, 2012 |
| First Posted : | June 29, 2012 (Estimate) |
| Results First Submitted : | February 9, 2021 |
| Results First Submitted that Met QC Criteria : | March 10, 2021 |
| Results First Posted : | April 6, 2021 |
| Last Update Submitted that Met QC Criteria : | March 10, 2021 |
| Last Update Posted : | April 6, 2021 |